Nuveen’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Nuveen’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,247,261	Closed	-$5.24M	–	3380
2023 Q1	$5.24M	Sell	1,247,261 -56,291	-4%	-$292K	﹤0.01%	1860
2022 Q4	$7.83M	Sell	1,303,552 -49,957	-4%	-$273K	﹤0.01%	1648
2022 Q3	$7.88M	Sell	1,353,509 -396,684	-23%	-$2.47M	﹤0.01%	1630
2022 Q2	$10.4M	Buy	+1,750,193	New	+$8.96M	﹤0.01%	1476
2016 Q2	–	Sell	-1,504	Closed	-$8	–	1480
2016 Q1	$8	Hold	1,504	–	–	﹤0.01%	1390
2015 Q4	$19	Buy	1,504 +343	+30%	+$4.58K	﹤0.01%	1495
2015 Q3	$17	Hold	1,161	–	–	﹤0.01%	1533
2015 Q2	$23	Hold	1,161	–	–	﹤0.01%	1577
2015 Q1	$21K	Buy	1,161 +121	+12%	+$2.72K	﹤0.01%	1570
2014 Q4	$25K	Sell	1,040 -40	-4%	-$925	﹤0.01%	1597
2014 Q3	$26K	Hold	1,080	–	–	﹤0.01%	1577
2014 Q2	$30K	Hold	1,080	–	–	﹤0.01%	1585
2014 Q1	$37K	Hold	1,080	–	–	﹤0.01%	1572
2013 Q4	$21K	Buy	+1,080	New	+$19.7K	﹤0.01%	1561

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Nuveen's CTIC Position: Q2 2023 in Review

Nuveen sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 1,247,261 shares — an estimated $5.24M sold.

Nuveen first reported a position in CTIC in Q4 2013 and held it in 14 quarters. The position peaked at $10.4M in Q2 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Nuveen reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Nuveen sold 1,247,261 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $5.24M.
Nuveen first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2013 and held it in 14 quarters.
Nuveen's CTI BioPharma Corp. (DE) Common Stock position peaked at $10.4M in Q2 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.